Cite

HARVARD Citation

    Ball, B. et al. (2021). The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy. American journal of hematology. 96 (5), pp. E171-E175. [Online]. 
  
Back to record